PHP
ALGN icon

Parkman Healthcare Partners’s Align Technology ALGN Stock Holding History

Parkman Healthcare Partners’s Portfolio ALGN Stock Details ALGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.23M Buy
36,963
+15,730
+74% +$2.73M 0.64% 52
2026
Q1 		$3.64M Sell
21,233
-4,052
-16% -$710K 0.38% 71
2025
Q4 		$3.95M Buy
+25,285
New +$3.62M 0.38% 71

Other funds holding ALGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Parkman Healthcare Partners's ALGN Position: Q2 2026 in Review

Parkman Healthcare Partners increased its Align Technology (ALGN) stake by 74% in Q2 2026, buying an estimated $2.73M and bringing the position to 36,963 shares worth $6.23M. The position accounts for 0.64% of the portfolio, ranked #52.

Parkman Healthcare Partners first reported a position in ALGN in Q4 2025 and has held it in 3 quarters since. 671 funds tracked by Wall St. Rank hold ALGN as of Q2 2026.

  • Parkman Healthcare Partners held 36,963 shares of Align Technology worth $6.23M as of Q2 2026.
  • Parkman Healthcare Partners bought 15,730 Align Technology shares in Q2 2026, an estimated $2.73M.
  • Align Technology made up 0.64% of Parkman Healthcare Partners's portfolio in Q2 2026, its #52 holding.
  • Parkman Healthcare Partners first reported a position in Align Technology in Q4 2025 and has held it in 3 quarters since.
  • 671 funds tracked by Wall St. Rank held Align Technology as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.